Mathematical model for BCG-based treatment of type 1 diabetes
From MaRDI portal
Publication:6156474
DOI10.1016/J.PHYSA.2023.128891OpenAlexW4377101861MaRDI QIDQ6156474FDOQ6156474
Authors: Teddy Lazebnik, Svetlana Bunimovich-Mendrazitsky, Alex Kiselyov 
Publication date: 13 June 2023
Published in: Physica A (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1016/j.physa.2023.128891
BCG treatment for T1Dclinical in-silico experimentsdiet-based treatment protocolNOD mice mathematical modeloptimal treatment analysis
Cites Work
- The MATLAB ODE Suite
- Title not available (Why is that?)
- Asymptotic equilibrium and stability of fuzzy differential equations
- Modelling the onset of Type 1 diabetes: can impaired macrophage phagocytosis make the difference between health and disease?
- Mathematical model of BCG immunotherapy in superficial bladder cancer
- Differential equations, dynamical systems, and an introduction to chaos
- Additional extension of the mathematical model for BCG immunotherapy of bladder cancer and its validation by auxiliary tool
- Solving Index-1 DAEs in MATLAB and Simulink
- Existence of solutions for nonlinear implicit differential equations: an equilibrium problem approach
- Stability analysis of delayed immune response BCG infection in bladder cancer treatment model by stochastic perturbations
- \textit{BCG} and \(IL-2\) model for bladder cancer treatment with fast and slow dynamics based on SPVF method -- stability analysis
- EXISTENCE AND STABILITY RESULTS FOR COUPLED SYSTEM OF FRACTIONAL DIFFERENTIAL EQUATIONS INVOLVING AB-CAPUTO DERIVATIVE
- EXISTENCE RESULTS FOR MULTI-TERM FRACTIONAL DIFFERENTIAL EQUATIONS WITH NONLOCAL BOUNDARY CONDITIONS INVOLVING ATANGANA–BALEANU DERIVATIVE
This page was built for publication: Mathematical model for BCG-based treatment of type 1 diabetes
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q6156474)
